colchicine

heart attack

Pharma

FDA approves Agepha’s version of colchicine for heart disease

Agepha Pharma of Slovakia has gained an FDA approval for Lodoco, which becomes the first drug to target cardiovascular inflammation.

Kevin Dunleavy Jun 20, 2023 8:10am

Takedas Shonan Research Center

Takeda loses again to Hikma in gout drug patent battle

May 24, 2016 9:23am